BerganKDV Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BerganKDV Wealth Management's BMY Position: Q2 2023 in Review
BerganKDV Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 6.3% in Q2 2023, selling an estimated $10.1K and leaving 2,229 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #257.
BerganKDV Wealth Management first reported a position in BMY in Q2 2018 and has held it in 21 quarters since. The position peaked at $189K in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- BerganKDV Wealth Management held 2,229 shares of Bristol-Myers Squibb worth $143K as of Q2 2023.
- BerganKDV Wealth Management sold 151 Bristol-Myers Squibb shares in Q2 2023, an estimated $10.1K.
- Bristol-Myers Squibb made up 0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #257 holding.
- BerganKDV Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 21 quarters since.
- BerganKDV Wealth Management's Bristol-Myers Squibb position peaked at $189K in Q2 2022.
- 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.